Surveillance Study of Women Taking Intrinsa® (EMPOWER)

This study has been terminated.
(The marketing authorization for Intrinsa was withdrawn.)
Sponsor:
Collaborator:
Procter and Gamble
Information provided by (Responsible Party):
Klaas Heinemann, MD, PhD, Center for Epidemiology and Health Research, Germany
ClinicalTrials.gov Identifier:
NCT00551785
First received: October 30, 2007
Last updated: November 1, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: No date given